H. Robert Superko

6.0k citations

117 papers · 4.6k indexed · 2 hit papers · h-index 33

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cardiology and Cardiovascular Medicine top 1%
- Cardiac Health and Mental Health

Papers in

Endocrinology, Diabetes and Metabolism 58
- Diabetes, Cardiovascular Risks, and Lipoproteins 52
Surgery 72
- Lipoproteins and Cardiovascular Health 68
- Coronary Interventions and Diagnostics 6

Co-authors: Ronald M. Krauss William L. Haskell Paul T. Williams Brenda Garrett Spencer B. King David J. Maron Peter D. Wood Joan M. Fair
Journals: The American Journal of Cardiology (17 papers)Circulation (10 papers)Journal of the American College of Cardiology (8 papers)Current Atherosclerosis Reports (5 papers)Atherosclerosis (5 papers)
Partner nations: United States Malaysia Canada

In The Last Decade

H. Robert Superko

115 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). 1994 · 638 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1994 Circulation
1988 New England Journal of Medicine

Peers

Countries citing papers authored by H. Robert Superko

Since Specialization

Citations

This map shows the geographic impact of H. Robert Superko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Robert Superko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Robert Superko more than expected).

Fields of papers citing papers by H. Robert Superko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Robert Superko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Robert Superko. The network helps show where H. Robert Superko may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H. Robert Superko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Robert Superko Line = papers co-authored together H. Robert Superko links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors Lipids in Health and Disease ·Michael L. Dansinger, Paul T. Williams, H. Robert Superko, Ernst J. Schaefer	2019	10
2	Coronary artery calcium testing: A call for universal coverage Preventive Medicine Reports ·Morteza Naghavi, David J. Maron, Robert A. Kloner, David S. Berman, Matthew J. Budoff, H. Robert Superko, Prediman K. Shah	2019	15
3	Cardiovascular Risk Factor Reduction in First Responders Resulting From an Individualized Lifestyle and Blood Test Program Journal of Occupational and Environmental Medicine ·Rosalynn Gill, H. Robert Superko, Jit Wei Aaron Ang, M. Hazewinkel, Rini Setiowati Rini Setiowati, Yongzhi Bi, J.K. Krishnan, Joi A. Gleason, Paul T. Williams, Michael L. Dansinger	2018	8
4	Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD The Journal of Clinical Endocrinology & Metabolism ·Fernando Bril, John J. Sninsky, Arthur M. Baca, H. Robert Superko, Чичерин Леонид Петрович, Diane Biernacki, Maryann Maximos, Romina Lomonaco, Beverly Orsak, Amitabh Suman, Michelle Weber, Michael J. McPhaul, Kenneth Cusi	2015	136
5	High-density lipoprotein subclasses and their relationship to cardiovascular disease Journal of clinical lipidology ·H. Robert Superko, Lakshmana Pendyala, Paul T. Williams, Shinya Nakai, Spencer B. King, Brenda Garrett	2012	109
6	ASYMPTOMATIC FIREFIGHTERS WITH METABOLIC SYNDROME HAVE A HIGH INCIDENCE OF BOTH CORONARY AND CAROTID PREMATURE ATHEROSCLEROSIS-ASSOCIATED WITH INCREASED THROMBOTIC AND INFLAMMATORY MARKERS Journal of the American College of Cardiology ·Lakshmana Pendyala, И В Подкуркова, Brenda Garrett, Laura Valentina Romero Rincón, Kathryn M. Momary, H. Robert Superko	2010	0
7	Effect of Combination Nicotinic Acid and Gemfibrozil Treatment on Intermediate Density Lipoprotein, and Subclasses of Low Density Lipoprotein and High Density Lipoprotein in Patients With Combined Hyperlipidemia The American Journal of Cardiology ·H. Robert Superko, Brenda Garrett, Spencer B. King, Kathryn M. Momary, Nicolas A.F. Chronos, Peter D. Wood	2008	10
8	Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I The American Journal of Cardiology ·H. Robert Superko, Mark E. McGovern, N Kuakuvi, Brenda Garrett	2004	27
9	Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a) Journal of the American College of Cardiology ·H. Robert Superko, Ronald M. Krauss	2000	85
10	Did grandma give you heart disease? The new battle against coronary artery disease The American Journal of Cardiology ·H. Robert Superko	1998	40
11	CURRENT AND FUTURE TRENDS IN THERAPY FOR DYSLIPIDEMIAS Endocrine Practice ·H. Robert Superko	1997	1
12	Elevated High-Density Lipoprotein Cholesterol, Not Protective in the Presence of Homocysteinemia The American Journal of Cardiology ·H. Robert Superko	1997	7
13	Task force 4. Efficacy of risk factor management Journal of the American College of Cardiology ·James S. Forrester, C. Noel Bairey Merz, Trudy L. Bush, Jay N. Cohn, Donald B. Hunninghake, Sampath Parthasarathy, H. Robert Superko	1996	33
14	Cost‐Effective treatment of coronary artery disease—the new imperative Clinical Cardiology ·H. Robert Superko	1996	7
15	Case Management System for Coronary Risk Factor Modification following Acute Myocardial Infarction, A Annals of Internal Medicine ·Robert F. DeBusk, Adriana Castreghini de Freitas Pereira, H. Robert Superko, André Serra Blay, مسعود درخشی, A. Baumg�rtner, 성보현, Afrin Nur Maidah, Ana Luísa Melo Silva, David L. Gee	1994	10
16	Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease Atherosclerosis ·H. Robert Superko, William L. Haskell, Ronald M. Krauss	1993	31
17	Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia The American Journal of Cardiology ·H. Robert Superko, Philip Greenland, Ralph A Manchester, Э.Э. Досадина, Gordon Schectman, AWAKE Collaboration, Donald B. Hunninghake, William L. Haskell, Jeffrey L. Probstfield	1992	39
18	Differential effects of nicotinic acid in subjects with different LDL subclass patterns Atherosclerosis ·H. Robert Superko, Ronald M. Krauss	1992	113
19	Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation The American Journal of Cardiology ·H. Robert Superko, William L. Haskell, 慎一加治	1990	32
20	Correlations of adipose tissue lipoprotein lipase activity with plasma lipoprotein subfractions in overweight men Federation Proceedings ·Howard I. Maibacu, 沈继发, H. Robert Superko, Richard B. Terry, Frank T. Lindgren, P D Wood	1985	2

About H. Robert Superko

H. Robert Superko is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cancer Research, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 117 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (68 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (52 papers), Cancer, Lipids, and Metabolism (23 papers), Cardiac Imaging and Diagnostics (10 papers), Atherosclerosis and Cardiovascular Diseases (8 papers), Pharmacology and Obesity Treatment (7 papers), Coronary Interventions and Diagnostics (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Cardiology and Cardiovascular Medicine (1.3k citations), Surgery (2.0k citations), Complementary and alternative medicine (284 citations) and Cancer Research (452 citations). H. Robert Superko has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Ronald M. Krauss, William L. Haskell, Paul T. Williams, Brenda Garrett, Spencer B. King, David J. Maron, Peter D. Wood, Joan M. Fair, Sally Mackey and Mary Ann Champagne. Their work appears in journals such as The American Journal of Cardiology, Circulation, Journal of the American College of Cardiology, Current Atherosclerosis Reports and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact